Invesco India Launches New Pharma & Healthcare Fund NFO
By Business Desk
Invesco India opens its new Pharma and Healthcare Fund NFO on Aug 18, 2026. Minimum investment ₹1,000. Explore healthcare sector growth.
Invesco India has launched its new fund offer, or NFO, for the Invesco India Pharma and Healthcare Fund Regular Payout Inc Dist cum Cap Wdrl. This scheme provides a fresh investment opportunity for those interested in the healthcare sector, as detailed by HDFCSky.
Key Fund Details
- NFO (New Fund Offer): A new investment scheme available for subscription.
- NAV (Net Asset Value): The fund’s initial value is set at 10.
- Open Date: Investors can subscribe starting August 18, 2026.
- Close Date: The subscription window concludes on September 1, 2026.
- Minimum Investment: The lowest amount to invest is ₹1,000.
The core objective of this fund is to deliver returns that align with the total return of specific securities. These securities are those represented by its underlying index, which the fund aims to track closely.
This objective, however, operates subject to tracking error, which is how closely a fund’s returns match its benchmark index. It means the fund aims to minimize any difference between its performance and the index it follows.
Invesco India, the fund’s issuer, also offers a range of other mutual funds. These additional investment options are also listed and detailed on the HDFCSky platform.